Allied Corp has shipped THC based medical cannabis flower from its cultivation and processing facilities located in Colombia to Australia.
The medical cannabis industry in Australia is experiencing substantial growth with an increased number of patients using cannabis to treat conditions like pain, anxiety and seizures, among others. The TGA Authorised Prescribers patient data reveals that there were 307,000 patients in the first half of 2023, versus 137,000 in the same period in 2022 ( source: click link here ). This remarkable rise in adoption underscores the country’s evolving healthcare landscape as it is set to become one of the largest markets for medical cannabis globally.
“On the heels of the recent expansion of our commercial team, they have performed. We are excited for the team to continue to scale up sales activities internationally.” says Calum Hughes, CEO.
For more information:
Allied Corp
allied.health